2023
DOI: 10.1080/2314808x.2023.2204258
|View full text |Cite
|
Sign up to set email alerts
|

Histological and immunohistochemical study of the effect of liraglutide in experimental model of non-alcoholic fatty liver disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 58 publications
0
0
0
Order By: Relevance
“…Liraglutide at therapeutic doses leads to a reduction in the expression of the gene procollagen type III amino-N-terminal peptide (PIIINP), which is responsible. About liver cell fibrosis, and the drug liraglutide has been proven to increase autophagy processes, including autophagy of fats and repair cells damaged by their accumulation, but at prescribed and fixed doses [18]. When using Orlistat with herbs, a significant improvement in the drug's performance was observed.…”
Section: Obese Pregnant Group Treated With Over Doses Of Liraglutidementioning
confidence: 99%
“…Liraglutide at therapeutic doses leads to a reduction in the expression of the gene procollagen type III amino-N-terminal peptide (PIIINP), which is responsible. About liver cell fibrosis, and the drug liraglutide has been proven to increase autophagy processes, including autophagy of fats and repair cells damaged by their accumulation, but at prescribed and fixed doses [18]. When using Orlistat with herbs, a significant improvement in the drug's performance was observed.…”
Section: Obese Pregnant Group Treated With Over Doses Of Liraglutidementioning
confidence: 99%